Quantcast

Latest multiple sclerosis Stories

2014-10-21 08:28:24

Through music and resources Our Voice in Song(TM) inspires people living with relapsing MS to become more active managers of their disease EAST HANOVER, N.J., Oct. 21, 2014 /PRNewswire/ -- Today Novartis Pharmaceuticals Corporation launched a new multifaceted multiple sclerosis (MS) awareness campaign aimed to motivate people with relapsing MS to take charge of their disease. The campaign, Our Voice in Song(TM), features inspirational advocate and music artist David Osmond, who...

2014-10-19 16:21:24

Largest retrospective study of its kind reveals that nearly 60 percent of patients with both uveitis and MS are diagnosed with each within a 5-year span CHICAGO, Oct. 19, 2014 /PRNewswire-USNewswire/ -- The results of the largest retrospective study of multiple sclerosis (MS) in uveitis patients has revealed that nearly 60 percent of patients with both diseases were diagnosed with each within a five-year span. The study is being presented today at AAO 2014, the 118(th) annual...

2014-10-16 23:09:03

New radio show from MSology.com features interviews with nurses who provide tips on pregnancy, exercise and lifestyle. Montreal, Quebec (PRWEB) October 16, 2014 Since its launch in 2012, MSology.com has provided news, feature articles and practical tips to over 100,000 people worldwide. To mark its second anniversary, MSology has now launched MS Radio, an audio program available exclusively on MSology.com. The first episode, available at...

2014-10-14 20:22:09

LONDON, Oct. 14, 2014 /PRNewswire/ -- This BCC Research study offers an overview of the multiple sclerosis (MS) disease-modifying product market, including regulatory issues accompanied by detailed analyses and forecasts by product. Its main objective is to present a comprehensive analysis of the current market for MS disease-modifying products and to forecast this marketâEUR(TM)s future direction through 2018. Special focus is placed on how new products and technologies will affect...

2014-10-13 08:26:58

- Stowe to be Joined by Leading Neurologists and People Living with the Disease for Live Events Nationwide - CAMBRIDGE, Mass., Oct. 13, 2014 /PRNewswire/ -- Genzyme, a Sanofi company, announced today that it is collaborating with television and film actress Madeleine Stowe to launch "Lights, Camera, Take Action on MS," a campaign intended to educate and empower people living with multiple sclerosis (MS) to take action to help manage their disease. Madeleine, who was a care partner to her late...

2014-10-02 08:30:16

- What do exercise, skin cells and gut bacteria have in common? They are among the new leads being explored to move us closer to a world free of MS- NEW YORK, Oct. 2, 2014 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society has committed nearly $19 million to support an expected 54 new MS research projects. These are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost, and ending the disease forever....

2014-09-30 23:13:38

Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy is a new OT PT Continuing Education courses designed to deliver new rehab information on the treatment of Multiple Sclerosis and Peripheral Neuropathy. Franklin, TN (PRWEB) September 30, 2014 Neuromuscular and central nervous system diseases affect millions of people throughout the United States and worldwide. It is estimated that 50,000-60,000 new cases of Parkinson’s Disease are diagnosed each...

2014-09-29 23:09:43

Early Evidence Published in Multiple Sclerosis and Related Disorders Suggests Value Treatment Effectiveness New York, NY (PRWEB) September 29, 2014 Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders. The study, which is the first of its kind, was conducted by researchers at Mount Sinai, Celgene Cellular Therapeutics...

2014-09-22 08:26:16

TOORAK, Australia, Sept. 22, 2014 /PRNewswire/ -- Antisense Therapeutics (the "Company" or "ANP") is pleased to report the publication of previously generated Phase IIa clinical trial data on ATL1102 in the medical journal Neurology. The article titled "CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS", is currently available online and will be included in the print edition Volume 83, November 11, 2014. The article highlights the...

2014-09-12 23:00:59

In what may be the largest study of sleep problems among individuals with multiple sclerosis (MS), researchers at UC Davis have found that widely undiagnosed sleep disorders may be at the root of the most common and disabling symptom of the disease: fatigue. Sacramento, CA (PRWEB) September 12, 2014 In what may be the largest study of sleep problems among individuals with multiple sclerosis (MS), researchers at UC Davis have found that widely undiagnosed sleep disorders may be at the root...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.